Your browser doesn't support javascript.
loading
Adoption of antithrombotic stewardship and utilization of clinical decision support systems-A questionnaire-based survey in Dutch hospitals.
Graafsma, Jetske; Klopotowska, Joanna E; Derijks, Hieronymus J; van de Garde, Ewoudt M W; Hoge, Rien H L; Kruip, Marieke J H A; Meijer, Karina; Karapinar-Carkit, Fatma; van den Bemt, Patricia M L A.
Afiliação
  • Graafsma J; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Klopotowska JE; Department of Medical Informatics Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Derijks HJ; Amsterdam Public Health Institute, Amsterdam, the Netherlands.
  • van de Garde EMW; Department of Pharmacy, Jeroen Bosch Hospital, Den Bosch, the Netherlands.
  • Hoge RHL; Department of Pharmacy, St. Antonius Hospital, Nieuwegein, Utrecht, the Netherlands.
  • Kruip MJHA; Division Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, the Netherlands.
  • Meijer K; Department of Pharmacy, Wilhelmina Hospital, Assen, the Netherlands.
  • Karapinar-Carkit F; Gaston Medical, Eindhoven, the Netherlands.
  • van den Bemt PMLA; Department of Hematology, Erasmus MC, Erasmus University medical center, Rotterdam, the Netherlands.
PLoS One ; 19(6): e0306033, 2024.
Article em En | MEDLINE | ID: mdl-38905283
ABSTRACT
Antithrombotics require careful monitoring to prevent adverse events. Safe use can be promoted through so-called antithrombotic stewardship. Clinical decision support systems (CDSSs) can be used to monitor safe use of antithrombotics, supporting antithrombotic stewardship efforts. Yet, previous research shows that despite these interventions, antithrombotics continue to cause harm. Insufficient adoption of antithrombotic stewardship and suboptimal use of CDSSs may provide and explanation. However, it is currently unknown to what extent hospitals adopted antithrombotic stewardship and utilize CDSSs to support safe use of antithrombotics. A semi-structured questionnaire-based survey was disseminated to 12 hospital pharmacists from different hospital types and regions in the Netherlands. The primary outcome was the degree of antithrombotic stewardship adoption, expressed as the number of tasks adopted per hospital and the degree of adoption per task. Secondary outcomes included characteristics of CDSS alerts used to monitor safe use of antithrombotics. All 12 hospital pharmacists completed the survey and report to have adopted antithrombotic stewardship in their hospital to a certain degree. The median adoption of tasks was two of five tasks (range 1-3). The tasks with the highest uptake were drafting and maintenance of protocols (100%) and professional's education (58%), while care transition optimization (25%), medication reviews (8%) and patient counseling (8%) had the lowest uptake. All hospitals used a CDSS to monitor safe use of antithrombotics, mainly via basic alerts and less frequently via advanced alerts. The most frequently employed alerts were identification of patients using a direct oral anticoagulant (DOAC) or a vitamin K antagonist (VKA) with one or more other antithrombotics (n = 6) and patients using a VKA to evaluate correct use (n = 6), both reflecting basic CDSS. All participating hospitals adopted antithrombotic stewardship, but the adopted tasks vary. CDSS alerts used are mainly basic in their logic.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistemas de Apoio a Decisões Clínicas / Fibrinolíticos / Hospitais Limite: Humans País/Região como assunto: Europa Idioma: En Revista: PLoS One Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistemas de Apoio a Decisões Clínicas / Fibrinolíticos / Hospitais Limite: Humans País/Região como assunto: Europa Idioma: En Revista: PLoS One Ano de publicação: 2024 Tipo de documento: Article